Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.79), $0.74 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $499 million versus the consensus estimate of $473.29 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.